Our illuminating molecules enhances the doctors ability to see disease tissue clearly improving their ability to treat cancer, autoimmune and other diseases.
View all
BioMarin Pharmaceutical
Post IPO Debt • San Rafael, United States
Regeneron
Post IPO Equity • Tarrytown, United States
Verve Therapeutics
Series B • Cambridge, United States
Biogen
Cambridge, United States
Imvax
Series C • Philadelphia, United States
Guardant Health
Venture • Redwood City, United States
Genentech
Venture • South San Francisco, United States
Zymo Research
Irvine, United States
Embark Veterinary
Series B • Boston, United States
Culture Biosciences
Series B • South San Francisco, United States
Celsius Therapeutics
Series B • Cambridge, United States
ARCA biopharma
Westminster, United States